SCHEMBL16619656

SCHEMBL16619656

CCOC(=O)c1ccc(CC2CCC(C(O[Si](C)(C)C(C)(C)C)c3cccnc3)N2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KMT2A Q03164 1/20 0.35
POLB P06746 3/20 0.34
GAA P10253 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GPR119 Q8TDV5 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP3A5 P20815 1/20 0.33
ATM Q13315 1/20 0.33
GLA P06280 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17986583 1.00 MAPT (0.37) MAPTKDM4ENPC1USP2ALDH1A1
SCHEMBL17986534 1.00 MAPT (0.37) MAPTKDM4ENPC1USP2ALDH1A1
SCHEMBL18210791 0.92 HDAC1 (0.38) MAPTKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL16619092 0.92 HDAC1 (0.38) MAPTKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL16629708 0.92 HDAC1 (0.38) MAPTKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL17986557 0.92 HDAC1 (0.38) MAPTKDM4EALDH1A1SMN1; SMN2HSD17B10
SCHEMBL16619101 0.91 ADRB3 (0.35) GPR119CYP3A4CYP3A5SLC6A2SLC6A4
SCHEMBL18017422 0.91 ADRB3 (0.35) GPR119CYP3A4CYP3A5SLC6A2SLC6A4
SCHEMBL9932786 0.91 ADRB3 (0.35) GPR119CYP3A4CYP3A5SLC6A2SLC6A4
SCHEMBL9932785 0.91 ADRB3 (0.35) GPR119CYP3A4CYP3A5SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed